Solid Tumor Clinical Trials in The Bronx, New York

4 studies are recruiting for solid tumor in The Bronx, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

   This is a first-in-human Phase I/II, open-label, multicenter, dose-escalation and expansion study designed to evaluate the safety, pharmacokinetics, and preliminary activity of GDC-7035 as a single agent and in combination with other anti-cancer therapies in participants with advanced or metastatic…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Montefiore Einstein Cancer Center, The Bronx, New York

   Locations

   49 in total

   Run by

   Genentech, Inc.

   See if you can join NCT06619587 on ClinicalTrials.gov

2. Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

   This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn …

   Stage

   Not phased

   Ages

   Any age

   Site

   Montefiore Medical Center - Moses Campus, The Bronx, New York

   Locations

   164 in total

   Run by

   Children's Oncology Group

   See if you can join NCT00736749 on ClinicalTrials.gov

3. Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

   This is a Phase 1/2, open-label, non-randomized, 4-part trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizuma…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   42 in total

   Run by

   Inhibrx Biosciences, Inc

   See if you can join NCT04198766 on ClinicalTrials.gov

4. Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

   The purpose of this study is to translate and tailor for Latinx participants a program called Communicating with Oncology Nurses about Values from the Outset (CONVO). In CONVO, routine cancer care for each participant includes a discussion between the nurse and participant about the participant's h…

   Stage

   Not phased

   Ages

   21 and older

   Site

   SBH Health System, The Bronx, New York

   Locations

   5 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT04942717 on ClinicalTrials.gov